Transcriptomic Characterization of Hypermutated Microsatellite Stable Tumors Reveals Distinct Proliferative and Immune Signatures
This study characterizes hypermutated microsatellite stable tumors across colorectal and endometrial cancers as a distinct biological subgroup defined by shared upregulation of immune and proliferative pathways (such as mTORC1, E2F, and G2M checkpoints) alongside cancer-specific regulatory features, notably involving SLC7A11 and microRNA interactions.